These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9661815)

  • 21. Affinity maturation of a V(H)H by mutational hotspot randomization.
    Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J
    J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
    Yelton DE; Rosok MJ; Cruz G; Cosand WL; Bajorath J; Hellström I; Hellström KE; Huse WD; Glaser SM
    J Immunol; 1995 Aug; 155(4):1994-2004. PubMed ID: 7636250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating the binding properties of an anti-17beta-estradiol antibody by systematic mutation combinations.
    Lamminmäki U; Westerlund-Karlsson A; Toivola M; Saviranta P
    Protein Sci; 2003 Nov; 12(11):2549-58. PubMed ID: 14573866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
    Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
    J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of loss and change of specificity resulting from random mutagenesis of an antibody VH region.
    Casson LP; Manser T
    J Immunol; 1995 Dec; 155(12):5647-54. PubMed ID: 7499849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a large synthetic human scFv library with six diversified CDRs and high functional diversity.
    Yang HY; Kang KJ; Chung JE; Shim H
    Mol Cells; 2009 Feb; 27(2):225-35. PubMed ID: 19277506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of antibody heavy chain CDR1 to digoxin binding analyzed by random mutagenesis of phage-displayed Fab 26-10.
    Short MK; Jeffrey PD; Kwong RF; Margolies MN
    J Biol Chem; 1995 Dec; 270(48):28541-50. PubMed ID: 7499368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage display aided improvement of a unique prostate-specific antigen (PSA) antibody unreactive with Lys(145)-Lys(146) internally cleaved forms.
    Liton MF; Peltola MT; Vehniäinen M; Kuusela E; Pettersson T; Lamminmäki U; Pettersson K; Brockmann EC
    J Immunol Methods; 2015 Jul; 422():72-9. PubMed ID: 25889751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
    J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants.
    De Pascalis R; Gonzales NR; Padlan EA; Schuck P; Batra SK; Schlom J; Kashmiri SV
    Clin Cancer Res; 2003 Nov; 9(15):5521-31. PubMed ID: 14654532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.
    Hofer T; Tangkeangsirisin W; Kennedy MG; Mage RG; Raiker SJ; Venkatesh K; Lee H; Giger RJ; Rader C
    J Immunol Methods; 2007 Jan; 318(1-2):75-87. PubMed ID: 17140598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heavy chain CDR3 optimization of a germline encoded recombinant antibody fragment predisposed to bind the U1A protein.
    de Wildt RM; Ruytenbeek R; van Venrooij WJ; Hoet RM
    Protein Eng; 1997 Jul; 10(7):835-41. PubMed ID: 9342149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligation-based assembly for constructing mouse synthetic scFv libraries by chain shuffling with in vivo-amplified VH and VL fragments.
    Nishi M; Jian N; Yamamoto K; Seto H; Nishida Y; Tonoyama Y; Shimizu N; Nishi Y
    J Immunol Methods; 2014 Oct; 412():53-69. PubMed ID: 25010461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural insights into steroid hormone binding: the crystal structure of a recombinant anti-testosterone Fab fragment in free and testosterone-bound forms.
    Valjakka J; Takkinenz K; Teerinen T; Söderlund H; Rouvinen J
    J Biol Chem; 2002 Feb; 277(6):4183-90. PubMed ID: 11707437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library.
    Gram H; Marconi LA; Barbas CF; Collet TA; Lerner RA; Kang AS
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3576-80. PubMed ID: 1565653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function studies of an anti-asialo GM1 antibody obtained from a phage display library.
    Qiu JX; Kai M; Padlan EA; Marcus DM
    J Neuroimmunol; 1999 Jun; 97(1-2):172-81. PubMed ID: 10408972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies.
    Daugherty PS; Chen G; Iverson BL; Georgiou G
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2029-34. PubMed ID: 10688877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.